DGE invites clinical innovation and development experts, patient recruitment specialists, and clinical safety/regulatory affairs officers, to attend the 7th Decentralized & Hybrid Clinical Trials Summit to be held in Philadelphia, PA, May 10-11, 2023.
Over 50% of clinical trials are likely to be decentralized by 2024. The size of virtual clinical trial data is overtaking traditional clinical trial processes requiring an advanced data science paradigm. Getting real-time AI/ML-driven insights can help research teams cut the time and cost of clinical trials while accelerating new drugs to market.
The 7th Decentralized & Hybrid Clinical Trials Summit will focus on leveraging AI/ML insights to enable more precise decision-making in remote trials. Attendees will learn how real-time AI/ML-driven insights are enabling key workflows in DCTs and risk-based quality management (RBQM).
It’s a great opportunity to address common DCT misperceptions and mistakes. At the same time, attendees will be able to consider the impact of improving patient safety and study quality while reducing cost and time.
To learn more, please visit https://ibn.fm/IBbV1